Medtronic MDT Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
Deferred revenue at January 23, 2026 and April 25, 2025 was $468 million and $446 million, respectively. At January 23, 2026 and April 25, 2025, $373 million and $354 million was included in other accrued expenses, respectively, and $95 million and $92 million was included in other liabilities, respectively. During the nine months ended January 23, 2026, the Company recognized $314 million of revenue that was included in deferred revenue as of April 25, 2025. During the nine months ended January 24, 2025, the Company recognized $251 million of revenue that was included in deferred revenue as of April 26, 2024.
Item 1. Financial Statements
FAQ
- What is Medtronic's contract liabilities?
- Medtronic (MDT) reported contract liabilities of $468M in Q4 2025.
- How has Medtronic's contract liabilities changed year-over-year?
- Medtronic's contract liabilities increased by 1.3% year-over-year, from $462M to $468M.
- What is the long-term trend for Medtronic's contract liabilities?
- Over 4 years (2021 to 2025), Medtronic's contract liabilities has grown at a 4.9% compound annual growth rate (CAGR), from $368M to $446M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Medtronic's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
